That’s why, as a 2016 Vox investigation found, there are many reports of vitamins and supplements containing ingredients that ...

Hims & Hers Health said fourth-quarter revenue surged as demand for its weight-loss treatments took off throughout the year amid a competitor supply shortage. The telehealth-consultation platform ...

Hims & Hers Health reported fourth-quarter results on Monday that beat analysts' expectations, but the stock sank in extended trading. Revenue increased 95% from a year earlier to $481 million ...

Shares of Hims & Hers Health (HIMS) sank in after-hours trading after the healthcare company reported earnings for its fourth quarter of Fiscal Year 2024 that were accompanied by a solid outlook.

The blistering rally in Hims & Hers Health Inc. that’s captivated meme-stock traders has ground to a halt, setting up a pivotal test when the telehealth company reports earnings after the market ...

Hims & Hers Health stock opened at $49.10 on Friday. The business’s 50-day simple moving average is $35.05 and its two-hundred day simple moving average is $25.70. The company has a market cap ...

Hims & Hers Health shares swooned after the Food & Drug Administration said the active ingredient in Ozempic and Wegovy is no longer in short supply. The company makes compounded versions of ...

Hims & Hers has shown exceptional growth, with a 1,000% appreciation since our first bullish rating, driven by strong growth, margins, and strategic expansions. Despite the impressive ...

The acquisition will strengthen the long-term durability of the company’s domestic supply chain, helping to ensure Americans can consistently access personalized medications Hims & ...

Hims & Hers acquired a California-based peptide facility to strengthen its supply chain, improve quality control, and expand personalized tr The FDA announced the semaglutide shortage was resolved ...

(staged scene) Photo: Roberto Pfeil/dpa (Photo by Roberto Pfeil/picture alliance via Getty Images) Hims & Hers Health (NYSE:HIMS) stock might surge. However, there’s significant risk. HIMS stock ...